Literature DB >> 8208816

Global flap ischemia: a comparison of arterial versus venous etiology.

C L Kerrigan1, P Wizman, V E Hjortdal, J Sampalis.   

Abstract

It has been suggested by clinical observations that acute venous thrombosis following free-flap surgery results in more severe tissue injury than postoperative arterial thrombosis. This current study, in the pig model, was designed (1) to determine the rate of survival and the percentage area of flap survival in both cutaneous and myocutaneous flaps following a secondary venous ischemic insult, (2) to compare this with findings following a secondary arterial ischemic insult, and (3) to determine the reliability of laser Doppler flowmetry and dermofluorometry index in the prediction of necrosis outcome following both venous and arterial ischemic insults. A total of 116 flaps were elevated in 29 pigs. Data analysis documented a decrease in the rate of flaps surviving venous ischemia as compared with arterial ischemia or control and of arterial ischemia as compared with control. In contrast to our previous work, a lower rate of buttock flaps survived a secondary ischemic insult (of either arterial or venous etiology) than did the cutaneous component of the myocutaneous flaps. As expected, as the length of ischemia increased, the rate of flaps surviving decreased, as did the percentage area of survival. Although laser Doppler performed slightly better than dermofluorometry index, as measured on immediate reperfusion following secondary venous ischemia, both were relatively poor predictors of eventual survival or necrosis. Under conditions of immediate reperfusion following secondary arterial ischemia, dermofluorometry index proved to be a superior predictor of ultimate necrosis as compared with laser Doppler flowmetry.

Entities:  

Mesh:

Year:  1994        PMID: 8208816

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  7 in total

1.  [Intra- and postoperative monitoring of transplanted flaps. Measurement of the partial pressure of oxygen in tissue].

Authors:  O Driemel; I Oberfahrenhorst; S G Hakim; H Kosmehl; H Pistner
Journal:  Mund Kiefer Gesichtschir       Date:  2004-09-18

2.  The role of the vacuum-assisted closure therapy in the salvage of venous congestion of the free flap: case report.

Authors:  Fatih Uygur; Haluk Duman; Ersin Ulkür; Bahattin Ceiköz
Journal:  Int Wound J       Date:  2008-01-03       Impact factor: 3.315

3.  Early detection of complete vascular occlusion in a pedicle flap model using quantitative [corrected] spectral imaging.

Authors:  Michael R Pharaon; Thomas Scholz; Scott Bogdanoff; David Cuccia; Anthony J Durkin; David B Hoyt; Gregory R D Evans
Journal:  Plast Reconstr Surg       Date:  2010-12       Impact factor: 4.730

4.  Novel Injury Site Targeted Fusion Protein Comprising Annexin V and Kunitz Inhibitor Domains Ameliorates Ischemia-Reperfusion Injury and Promotes Survival of Ischemic Rat Abdominal Skin Flaps.

Authors:  Victor Bong-Hang Shyu; Chung En Hsu; Chih-Jen Wen; Tze-Chein Wun; Rui Tang; Samuel Achilefu; Fu-Chan Wei; Hui-Yun Cheng
Journal:  Ann Plast Surg       Date:  2017-03       Impact factor: 1.539

Review 5.  Leech Therapy Protects Free Flaps against Venous Congestion, Thrombus Formation, and Ischemia/Reperfusion Injury: Benefits, Complications, and Contradictions.

Authors:  Alireza Mousavian; Soheil Sabzevari; Shafagh Parsazad; Hamidreza Moosavian
Journal:  Arch Bone Jt Surg       Date:  2022-03

6.  Ratio of Blood Glucose Level Change Measurement for Flap Monitoring.

Authors:  Ryo Karakawa; Hidehiko Yoshimatsu; Mitsunaga Narushima; Takuya Iida
Journal:  Plast Reconstr Surg Glob Open       Date:  2018-07-16

7.  Novel biomarkers of arterial and venous ischemia in microvascular flaps.

Authors:  Gerard K Nguyen; Brian H Hwang; Yiqiang Zhang; John F W Monahan; Gabrielle B Davis; Yong Suk Lee; Neli P Ragina; Charles Wang; Zhao Y Zhou; Young Kwon Hong; Ryan M Spivak; Alex K Wong
Journal:  PLoS One       Date:  2013-08-14       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.